Evaluating pediatric cancer through the lens of time
New study accounts for years of life lost due to cancer. It’s the first time this metric has been used to analyze the childhood cancer burden globally.
Learning from rare disorders
Science Advances highlights St. Jude research into rare inherited Lysosomal disorders caused by mutations in the NEU1 gene.
Researchers discover key genetic trigger that compromises cancer immunotherapy
T cell exhaustion has proven to be an obstacle for immunotherapy, and investigators hope their basic findings will result in techniques to prevent exhaustion.
Scientists follow the data to a surprise
Researchers surveyed the accumulation of toxic proteins in Alzheimer’s models, and discovered that a pathway nicknamed LANDO can limit the protein buildup.
Studying single cells to understand a type of pediatric brain tumor
Scientists completed the most in-depth study of medulloblastoma subtypes by studying single cells to help shed light on how cells become cancerous.
BRCA2 gene linked to risk of non-Hodgkin lymphoma
A St. Jude study linked inherited mutations in the BRCA2 gene with a higher risk of non-Hodgkin lymphoma.
From Promise, Autumn 2019